American Gene Technologies to Present at 2019 Cell & Gene Meeting on the Mesa
01 oct. 2019 14h51 HE
|
American Gene Technologies
ROCKVILLE, Md., Oct. 01, 2019 (GLOBE NEWSWIRE) -- American Gene Technologies announced today that its Chief Science Officer C. David Pauza, Ph.D. will present at the annual Cell & Gene Meeting...
HIV Cure Program of American Gene Technologies Adds University of Maryland School of Medicine’s Institute of Human Virology as New Study Site to Support the Development of a Cell and Gene Therapy for HIV
02 juil. 2019 16h33 HE
|
American Gene Technologies
ROCKVILLE, Md., July 02, 2019 (GLOBE NEWSWIRE) -- American Gene Technologies (AGT), a leading gene and cell therapy company based in Rockville, MD, selected the Institute of Human Virology (IHV) at...
HIV Cure Program Patent Granted To American Gene Technologies
21 mai 2019 08h30 HE
|
American Gene Technologies
ROCKVILLE, Md., May 21, 2019 (GLOBE NEWSWIRE) -- American Gene Technologies, a leading gene and cell therapy company based in Rockville, Md., was granted a second patent for its unique molecule,...
American Gene Technologies Congratulates Robert Redfield, M.D., on His Appointment as Director of the Centers for Disease Control and Prevention
28 mars 2018 08h30 HE
|
American Gene Technologies
ROCKVILLE, Md., March 28, 2018 (GLOBE NEWSWIRE) -- American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company, today congratulates Robert R. Redfield, M.D., on his...
American Gene Technologies Gains Additional Immuno-Oncology Patent
19 mars 2018 08h30 HE
|
American Gene Technologies
ROCKVILLE, Md., March 19, 2018 (GLOBE NEWSWIRE) -- American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company, today announced receipt of a second immuno-oncology...
American Gene Technologies Announces Progress toward Phase I Clinical Trial of AGT103-T for HIV Functional Cure
25 janv. 2018 09h30 HE
|
American Gene Technologies
ROCKVILLE, Md., Jan. 25, 2018 (GLOBE NEWSWIRE) -- American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company, today announced completion of the pilot runs of its...
American Gene Technologies Receives U.S. Patent on Novel Immuno-Oncology Methods of Treating Cancer through Activation of Gamma Delta T Cells
12 déc. 2017 09h00 HE
|
American Gene Technologies
ROCKVILLE, Md., Dec. 12, 2017 (GLOBE NEWSWIRE) -- American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company, today announced the issuance of U.S. Patent No:...
American Gene Technologies Inc. (AGT) Demonstrates Rationale of its Genetic Approach toward developing a Functional Cure for HIV Infection
12 oct. 2017 09h00 HE
|
American Gene Technologies
ROCKVILLE, Md., Oct. 12, 2017 (GLOBE NEWSWIRE) -- American Gene Technologies International Inc. (“AGT”), a gene therapy and technology company focusing on a lentiviral delivery platform, presented...
American Gene Technologies Inc. (AGT) CSO, David Pauza, to Present HIV Functional Cure data At The Cell & Gene Meeting on the Mesa
26 sept. 2017 09h00 HE
|
American Gene Technologies
ROCKVILLE, Md., Sept. 26, 2017 (GLOBE NEWSWIRE) -- American Gene Technologies International Inc. (AGT), a gene technology company focusing on a lentiviral delivery platform, today announced that...
American Gene Technologies Inc. Appoints Julia R. Brown to its Board of Directors
11 sept. 2017 12h29 HE
|
American Gene Technologies
ROCKVILLE, Md., Sept. 11, 2017 (GLOBE NEWSWIRE) -- American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company with a broad and robust lentiviral drug-development...